HCID 10761696, compound → HCID 10684170, compound
Reaction equation
C([N:8]1[CH2:13][CH2:12][CH:11]([N:14]([CH3:27])[C:15]2[C:20]([NH:21][C:22]([CH3:25])([CH3:24])[CH3:23])=[CH:19][CH:18]=[C:17]([F:26])[N:16]=2)[CH2:10][CH2:9]1)C1C=CC=CC=1.[H][H]>C(O)C.[OH-].[OH-].[Pd+2]>[CH3:27][N:14]([CH:11]1[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]1)[C:15]1[C:20]([NH:21][C:22]([CH3:25])([CH3:23])[CH3:24])=[CH:19][CH:18]=[C:17]([F:26])[N:16]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
1-Benzyl-4-[N-methyl-N-(3-tert-butylamino-6-fluoro-2-pyridinyl)amino]piperidine (EXAMPLE 153, 900 mg, 2.43 mmol) and palladium hydroxide on carbon (350 mg) in 50 ml ethanol is hydrogenated at 40 p.s.i. hydrogen for 24 hrs. Filtration and removal of the solvent gives the title compound, which is used without further purification, NMR (300 MHz, CD3OD) 7.38, 6.61, 3.16-3.27, 2.71-2.79, 2.56, 1.84, 1.61-1.66 and 1.33δ.
Workup
- filtrationFiltration and removal of the solvent
Sources & evidence
- ORD record
- ord-078d2ce2e9c24da0911d04bd02cf6abc
- Source dataset
- uspto-grants-1999_02
- Patent number
- US05866589
Reaction notes
Loading…